Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it will construct a new state of the art manufacturing facility in Mesa, Arizona for the company’s growing continuous glucose monitoring (CGM) business. This new, 180,000 square foot facility will support the company’s global manufacturing operations and is projected to create more than 500 jobs over the next several years.
“The move by Dexcom to locate their expanded operations to Mesa reinforces the data that shows the healthcare industry is growing position in innovative biomedical manufacturing operations,” said Chris Camacho, president & CEO of the Greater Phoenix Economic Council. “Dexcom’s presence in the market contributes to Greater Phoenix’s reputation as a center for healthcare innovation, and we look forward to seeing their growth over the next several years.”
Read the full release.